SCHEMBL5420484

SCHEMBL5420484

[c]1nnc(-c2cccnn2)o1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GOT1 P17174 1/20 0.31
DHODH Q02127 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30792004 0.71 GOT1 (0.46) GOT1DHODH
SCHEMBL29442588 0.71 GOT1 (0.46) GOT1DHODH
SCHEMBL1456807 0.71 GOT1 (0.46) GOT1DHODH
SCHEMBL2359774 0.70 KDM4E (0.58)
SCHEMBL12571337 0.67 HPGDS (0.41) GOT1DHODH
SCHEMBL13911004 0.67 GOT1 (0.42) GOT1DHODH
SCHEMBL18210549 0.65 GOT1 (0.31) GOT1
SCHEMBL8992127 0.65 GOT1 (0.31) GOT1
SCHEMBL7299303 0.65 KDM4E (0.37)
SCHEMBL26766188 0.65 BRD4 (0.36) GOT1DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070049594-A1 Novel compounds and compositions as cathepsin inhibitors AVENTIS PHARMACEUTICALS INC. (US) 2007-03-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049594-A1 Novel compounds and compositions as cathepsin inhibitors CTSS, CTSB, CTSE GOT1 1854/4885DHODH 2696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.